Revisor Wealth Management LLC

Position in JNJ — Johnson & Johnson

CIK 1887409 AKRON, OH

Position in JNJ

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$1,427,819

+$275,774 QoQ

Shares Held

5,622

+19.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.61%

of 13F equity value

Holder Rank

#2,641

of 4,664 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Revisor Wealth Management LLC holds $7,877,632 across 8 Drug Manufacturers - General names. JNJ ranks #2 (18.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GSK	GSK plc	30,786	$1,613,802
2	JNJ	Johnson & Johnson This page	5,622	$1,427,819
3	AMGN	Amgen Inc	3,075	$1,113,519
4	ABBV	AbbVie Inc.	3,399	$855,324
5	LLY	ELI LILLY & Co	712	$853,994
6	MRK	Merck & Co., Inc.	5,906	$758,921
7	PFE	Pfizer Inc	30,193	$727,047
8	NVS	Novartis AG	3,364	$527,206

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,427,819	5,622	+19.3%	Shares	Sole	2026-07-22
2026-03-31	$1,152,045	4,713	+2.5%	Shares	Sole	2026-04-27
2025-12-31	$951,763	4,599	+0.2%	Shares	Sole	2026-01-27
2025-09-30	$851,077	4,590	-13.7%	Shares	Sole	2025-10-15
2025-06-30	$812,019	5,316	-1.1%	Shares	Sole	2025-07-15
2025-03-31	$891,721	5,377	+108.5%	Shares	Sole	2025-04-28
2024-12-31	$372,974	2,579	-45.1%	Shares	Sole	2025-02-20
2024-09-30	$760,709	4,694	+6.0%	Shares	Sole	2024-11-12
2024-06-30	$647,050	4,427	-37.8%	Shares	Sole	2024-08-12
2024-03-31	$1,125,047	7,112	+171.0%	Shares	Sole	2024-04-23
2023-12-31	$411,285	2,624	-37.6%	Shares	Sole	2024-01-10
2023-09-30	$654,773	4,204	+44.4%	Shares	Sole	2023-11-16
2023-06-30	$481,994	2,912	+0.3%	Shares	Sole	2023-11-21
2023-03-31	$450,120	2,904	—	Shares	Sole	2023-11-21
No filing history on record for this holder in this stock.